Home / CAPG Knockout Cell Lines

CAPG Knockout Cell Lines

Gene: CAPG

Official Full Name: capping actin protein, gelsolin likeprovided by HGNC

Gene Summary: This gene encodes a member of the gelsolin/villin family of actin-regulatory proteins. The encoded protein reversibly blocks the barbed ends of F-actin filaments in a Ca2+ and phosphoinositide-regulated manner, but does not sever preformed actin filaments. By capping the barbed ends of actin filaments, the encoded protein contributes to the control of actin-based motility in non-muscle cells. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jan 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO06509 CAPG Knockout cell line (HeLa) Human CAPG 1:3~1:6 Negative Online Inquiry
KO06510 CAPG Knockout cell line (HCT 116) Human CAPG 1:2~1:4 Negative Online Inquiry
KO06511 CAPG Knockout cell line (HEK293) Human CAPG 1:3~1:6 Negative Online Inquiry
KO06512 CAPG Knockout cell line (A549) Human CAPG 1:3~1:4 Negative Online Inquiry

Background

CAPG Gene Knockout Cell Lines are meticulously engineered cellular models designed to study the specific functions of the CAPG gene, which encodes a protein crucial for actin dynamics and cell motility. These knockout cell lines are generated through precise genome editing techniques, such as CRISPR/Cas9, resulting in the complete ablation of CAPG expression. This pivotal alteration allows researchers to explore the mechanistic roles of CAPG in various cellular processes, including cytoskeletal organization, cellular shape maintenance, and migration.

The primary function of these knockout cell lines lies in their ability to provide insights into the biological implications of CAPG deficiency. CAPG is known to influence the actin cytoskeleton, impacting processes such as phagocytosis, wound healing, and tumor metastasis. By utilizing these cell lines, researchers can assess the downstream effects of CAPG ablation on cell behavior, molecular signaling pathways, and the tumor microenvironment, offering critical information that could inform therapeutic strategies for diseases involving abnormal cellular movement and adhesion.

In a research context, the CAPG Gene Knockout Cell Lines serve as invaluable tools in both basic and applied sciences. Their applications span from drug discovery, where the understanding of CAPG’s role can lead to novel therapeutic targets, to studying cancer biology through the lens of tumor cell behavior. Clinically, insights gained from these models could translate into better understanding of CAPG-associated pathologies, such as certain types of cancer and inflammatory diseases.

One of the distinct advantages of our CAPG Gene Knockout Cell Lines is the high fidelity of gene disruption, coupled with rigorous validation methods that ensure the reliability of experimental outcomes. Compared to traditional methods such as siRNA knockdown, which may only temporarily reduce gene expression and can lead to off-target effects, our knockout lines provide a stable, homogenous platform for long-term studies, significantly enhancing the reproducibility and robustness of results.

For researchers and clinicians focused on unraveling the complexities of cellular dynamics and their implications in health and disease, CAPG Gene Knockout Cell Lines offer a unique and powerful resource. Our dedication to advancing biological research through innovative product offering is driven by a profound understanding of cell biology and a commitment to providing high-quality tools for scientific discovery, making our cell lines not just a product, but a vital partner in your research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.